RaySearch Laboratories AB (CHIX:RAYBS) Owner Earnings per Share (TTM): -4.23 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:RAYBS RaySearch Laboratories AB CHIX:RAYBS
95 GF Score
Price kr234.70
GF Value kr236.21
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is RaySearch Laboratories AB Owner Earnings per Share (TTM)?

RaySearch Laboratories AB CHIX:RAYBS 95 Owner Earnings per Share (TTM) is -4.23 as of Jun. 2026. GuruFocus rates CHIX:RAYBS with a GF Score™ of 95/100 and a GF Value™ of kr236.21 (Fairly Valued). The stock has 2 warning signs investors should review. Among 298 Healthcare Providers & Services companies, RaySearch Laboratories AB ranks worse than 335570.13% on this metric.

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

RaySearch Laboratories AB's Owner Earnings per Share (TTM) ended in Jun. 2026 was kr-4.23. It's Price-to-Owner-Earnings ratio for today is 0.


The historical rank and industry rank for RaySearch Laboratories AB's Owner Earnings per Share (TTM) or its related term are showing as below:


During the past 13 years, the highest Price-to-Owner-Earnings ratio of RaySearch Laboratories AB was 4423.08. The lowest was 11.05. And the median was 117.58.


CHIX:RAYBs's Price-to-Owner-Earnings is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 17.93
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

RaySearch Laboratories AB's Earnings per Share (Diluted) for the three months ended in Jun. 2026 was kr0.57. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was kr6.21. It's PE Ratio (TTM) ratio for today is 37.79.

RaySearch Laboratories AB's EPS without NRI for the three months ended in Jun. 2026 was kr0.57. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2026 was kr6.21. It's PE Ratio without NRI ratio for today is 37.79.


Be Aware

Assumption: Companies usually do not report maintenance capital expenditures and growth capital expenditures separately. Here we use estimated numbers and average them over 5 years. The method to estimate maintenance capital expenditures can be found in above part 4.

Note: GuruFocus' Change In Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And it includes non-current parts of assets and liabilities.


RaySearch Laboratories AB Owner Earnings per Share (TTM) Related Terms


RaySearch Laboratories AB Owner Earnings per Share (TTM) Historical Data

* Premium members only.

The historical data trend for RaySearch Laboratories AB's Owner Earnings per Share (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RaySearch Laboratories AB Owner Earnings per Share (TTM) Chart

RaySearch Laboratories AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Owner Earnings per Share (TTM)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.51 -1.77 0.02 0.63 -2.30

RaySearch Laboratories AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Owner Earnings per Share (TTM) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.96 -3.68 -2.30 -3.20 0.00

CHIX:RAYBS vs VEEV, BTSG, HQY: Owner Earnings per Share (TTM) Comparison

For the Health Information Services subindustry, RaySearch Laboratories AB's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RaySearch Laboratories AB Price-to-Owner-Earnings vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, RaySearch Laboratories AB's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where RaySearch Laboratories AB's Price-to-Owner-Earnings falls into.


CHIX:RAYBS
95GF Score
RaySearch Laboratories AB CHIX:RAYBS
Owner Earnings per Share (TTM) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

RaySearch Laboratories AB Owner Earnings per Share (TTM) Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

To make it simple, then you will have:

Owner Earnings per Share (TTM) = (Net Income + Depreciation, Depletion and Amortization + Change In Deferred Tax - 5Y Average of Maintenance Capital Expenditure + Change In Working Capital) / Shares Outstanding (Diluted Average)

RaySearch Laboratories AB's Owner Earnings per Share (TTM) Calculation:

TTM / Last Quarter Average of Last 20 Quarters
Net Income 213
Depreciation, Depletion and Amortization 0
Change In Deferred Tax 0
5Y Average of Maintenance Capital Expenditure 180
Change In Working Capital -92
Shares Outstanding (Diluted Average) 34

1. Start with "Net Income" from income statement. RaySearch Laboratories AB's Net Income for the trailing twelve months (TTM) ended in Jun. 2026 was kr213 Mil.

2. "Depreciation, Depletion and Amortization" is from cashflow statement. RaySearch Laboratories AB's Depreciation, Depletion and Amortization for the trailing twelve months (TTM) ended in Jun. 2026 was kr0 Mil. This needs to be added back because company does not actually need to pay cash for it. It is a non-cash item.

3. Other non-cash charges usually include "Stock Based Compensation" and "Change In Deferred Tax":
However, to be conservative, GuruFocus will not add Stock Based Compensation back to net income. RaySearch Laboratories AB's Change In Deferred Tax for the trailing twelve months (TTM) ended in Jun. 2026 was kr0 Mil.

4. Average maintenance capital expenditure over a business/industry cycle: 5-Year Average Maintenance Capital Expenditure = kr180 Mil

It is usually best to take a long-term average of maintenance capital expenditure. Ideally this would be as long as 10 years and include at least one economic downturn. However, since many companies do not have as long as 10-year history, here GuruFocus uses the latest 5 years data to do the calculation. To smooth out unusual years but reflect recent developments, we take an average of the 5 year maintenance capital expenditure.

The following shows how to get maintenance capital expenditure.

First, calculate the revenue change regarding to the previous quarter. If the revenue decreased from the previous quarter, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
Second, if the revenue increased from the previous quarter, then calculate the percentage of Net PPE as of corresponding Revenue.
Growth Capital Expenditure = Percentage of Property, Plant and Equipment as of corresponding Revenue * Revenue Increase
Third, calculate Capital Expenditure (positive) - Growth Capital Expenditure.
If [Capital Expenditure (positive) - Growth Capital Expenditure] was negative, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
If [Capital Expenditure (positive) - Growth Capital Expenditure] was positive, then the Maintenance Capital Expenditure = Capital Expenditure (positive) - Growth Capital Expenditure.
Fourth, get the average of the 5 years maintenance capital expenditure.

RaySearch Laboratories AB's 5-Year Average Maintenance Capital Expenditure = kr180 Mil

5. "Change In Working Capital" is from cashflow statement. RaySearch Laboratories AB's Change In Working Capital for the trailing twelve months (TTM) ended in Jun. 2026 was kr-92 Mil.
Note: GuruFocus' Change in Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And sometimes it includes non-current parts of assets and liabilities.

6. RaySearch Laboratories AB's Shares Outstanding (Diluted Average) for the months ended in Jun. 2026 was 34.229 Mil.

RaySearch Laboratories AB's Onwer Earnings Per Share for Jun. 2026 is calculated as:

Owner Earnings per Share (TTM)
=( Net Income+Depreciation, Depletion and Amortization+Change In Deferred Tax
=( 213 +0+0
-5Y Avg of Maintenance CAPEX+Change In Working Capital )/Shares Outstanding (Diluted Average)
-180.42174704892+-92.2)/34.229
=-4.23

Price-to-Owner-Earnings=Current Price/Owner Earnings per Share (TTM)
=234.70/-4.23
=0

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Owner Earnings per Share (TTM) of -4.23 mean?
RaySearch Laboratories AB (CHIX:RAYBS) has a Owner Earnings per Share (TTM) of -4.23 as of Jun. 2026. Warren Buffett defined owner earnings as reported earnings plus depreciation less average maintenance capital expenditure. View historical data on RaySearch Laboratories AB. Over the past decade, RaySearch Laboratories AB's Owner Earnings per Share (TTM) has ranged from 11.05 to 4,423.08. According to the industry distribution chart, RaySearch Laboratories AB ranks #999999 out of 298 companies in the Healthcare Providers & Services industry.
Is RaySearch Laboratories AB's Owner Earnings per Share (TTM) too high?
RaySearch Laboratories AB's current Owner Earnings per Share (TTM) is -4.23. Over the past 10 years, this metric has ranged from a low of 11.05 to a high of 4,423.08. Based on the distribution chart, RaySearch Laboratories AB ranks #999999 out of 298 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, RaySearch Laboratories AB has a GF Score™ of 95/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does RaySearch Laboratories AB's Owner Earnings per Share (TTM) compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, RaySearch Laboratories AB ranks #999999 out of 298 companies for Owner Earnings per Share (TTM). This places RaySearch Laboratories AB in the lower half of its industry. The industry median Owner Earnings per Share (TTM) is 17.93. Historically, RaySearch Laboratories AB's own Owner Earnings per Share (TTM) has ranged from 11.05 to 4,423.08 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Owner Earnings per Share (TTM) for a Healthcare Providers & Services company?
The median Owner Earnings per Share (TTM) among Healthcare Providers & Services companies is 17.93, based on 298 companies in the industry. Companies in the top quartile (top 25%) have a Owner Earnings per Share (TTM) significantly above this median, while those in the bottom quartile fall well below. However, Owner Earnings per Share (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Owner Earnings per Share (TTM) mean?
A high Owner Earnings per Share (TTM) can signal that a stock is expensive relative to its fundamentals. Warren Buffett defined owner earnings as reported earnings plus depreciation less average maintenance capital expenditure. View historical data on RaySearch Laboratories AB. For the Healthcare Providers & Services industry, the median Owner Earnings per Share (TTM) is 17.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. RaySearch Laboratories AB's current Owner Earnings per Share (TTM) is -4.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RaySearch Laboratories AB stock overvalued right now?
Based on GuruFocus' analysis, RaySearch Laboratories AB (CHIX:RAYBS) is currently considered Fairly Valued. The stock's GF Value™ is kr236.21, compared to a current price of kr234.70 — trading 0.6% below its estimated fair value. The current Owner Earnings per Share (TTM) is -4.23. RaySearch Laboratories AB's overall GF Score™ is 95/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Owner Earnings per Share (TTM) calculated?
Owner Earnings per Share (TTM) is calculated from a company's financial statements. For RaySearch Laboratories AB (CHIX:RAYBS), the current Owner Earnings per Share (TTM) is -4.23 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is RaySearch Laboratories AB (CHIX:RAYBS) Overvalued in 2026?

Based on GuruFocus' analysis, RaySearch Laboratories AB stock appears to be undervalued. The current stock price of kr234.70 is trading 0.6% below its estimated GF Value™ of kr236.21. GuruFocus considers RaySearch Laboratories AB to be Fairly Valued.

Key valuation signals for CHIX:RAYBS:

  • Owner Earnings per Share (TTM): -4.23
  • GF Value™: kr236.21 vs. price of kr234.70 (0.6% below fair value)
  • GF Score™: 95/100 with 2 warning signs

No single metric tells the full story. See the CHIX:RAYBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


RaySearch Laboratories AB Business Description

Address Eugeniavagen 18C, Stockholm, SWE, 113 68
RaySearch Laboratories AB is a Sweden-based medical technology company. The company develops software solutions for improved cancer treatment. The company develops and markets the RayStation treatment planning system and RayCare oncology information system to clinics all over the world and distributes products through licensing agreements with medical technology companies. Its geographic segments consist of the Americas, Asia-Pacific & Middle East, Europe, and the rest of world.
95GF Score

Get the complete analysis for CHIX:RAYBS

Owner Earnings per Share (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr234.70
Price
kr236.21
GF Value